• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL UNCOVERED STENT; PYLORIC & DUODENAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TAEWOONG MEDICAL CO.,LTD. NITI-S PYLORIC & DUODENAL UNCOVERED STENT; PYLORIC & DUODENAL STENT Back to Search Results
Model Number DXDT2210
Device Problem Insufficient Information (3190)
Patient Problems Death (1802); Inflammation (1932)
Event Date 04/26/2019
Event Type  Death  
Manufacturer Narrative
It was reported that, the stent was placed from duodenal bulb to papilla.The procedure was successfully completed but 5 to 6 hours after the stent placement, the patient developed acute pancreatitis.The physician administered gabexate mesilate.3 days after the stent placement, treatment with medication had been taken, however, the patient passed away.It was confirmed from the device history record that device had been manufactured with no significant issue and passed all the inspections successfully.It is hard to identify the root cause because the suspected device was not returned and the information is insufficient such as the photo of placed stent.However, based on the description, which was written that "the procedure was successfully completed but the patient developed pancreatitis", "the physician commented that the stent placement was appropriate", and the further information, which was written that "it was reported that no possibility of pancreatitis could not be found.", it is assumed that the duodenal stent was placed normally according to physician's intention, but that compression of the duodenal papilla by the stent lead to increased pressure in the pancreatic duct, which results in acute pancreatitis.And it seems that the physician administered gabexate mesilate, but 3 day after stent placement, the patient passed away in the end.It is stated on user manual as follows.Potential complications: potential complications associated with the use of niti-s & comvi stent may include, but are not limited to: death (other than that due to normal disease progression).This suspected device is not registered in the us but we will continuously monitor the same or similar customer complaints through accurate analyses.
 
Event Description
On (b)(6) 2019: there was a neoplastic stenosis from descending part of duodenum to just above papilla.Therefore, the stent was placed from duodenal bulb to papilla.The procedure was successfully completed but the patient developed pancreatitis at night.On (b)(6) 2019: treatment with medication had been taken, however, the patient passed away.The physician commented that the stent placement was appropriate and requires the information about the same events and literature.Further information ((b)(6)) patient information: age (b)(6), male, duodenal cancer (cancer staging iii~iii, no more details available) (b)(6) 2019: stent was placed from duodenal bulb to papilla 5 to 6 hours after the stent placement, the patient developed acute pancreatitis.The physician administered gabexate mesilate.On (b)(6) 2019: the patient passed away due to the acute pancreatitis.Pathologic autopsy: no.Radiation treatment: no.Perforation: no.No procedure of ercp, etc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NITI-S PYLORIC & DUODENAL UNCOVERED STENT
Type of Device
PYLORIC & DUODENAL STENT
Manufacturer (Section D)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, 10022
KS  10022
Manufacturer (Section G)
TAEWOONG MEDICAL CO.,LTD.
14, gojeong-ro
wolgot-myeon
gimpo-si, 10022
KS   10022
Manufacturer Contact
lee
14, gojeong-ro
wolgot-myeon
gimpo-si, 10022
MDR Report Key8698576
MDR Text Key147987379
Report Number3003902943-2019-00022
Device Sequence Number1
Product Code MUM
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 05/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date01/23/2022
Device Model NumberDXDT2210
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/17/2019
Initial Date FDA Received06/14/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age67 YR
-
-